key: cord-0716156-y4kmiy8m authors: Wang, Julia Y.; Zhang, Wei; Roehrl, Victor B.; Roehrl, Michael W.; Roehrl, Michael H. title: An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19 date: 2022-03-24 journal: Front Immunol DOI: 10.3389/fimmu.2022.831849 sha: 7f6ccde5404f58b8f7591e44b31032b9c8132f59 doc_id: 716156 cord_uid: y4kmiy8m COVID-19 is accompanied by a myriad of both transient and long-lasting autoimmune responses. Dermatan sulfate (DS), a glycosaminoglycan crucial for wound healing, has unique affinity for autoantigens (autoAgs) from apoptotic cells. DS-autoAg complexes are capable of stimulating autoreactive B cells and autoantibody production. We used DS-affinity proteomics to define the autoantigen-ome of lung fibroblasts and bioinformatics analyses to study the relationship between autoantigenic proteins and COVID-induced alterations. Using DS-affinity, we identified an autoantigen-ome of 408 proteins from human HFL1 cells, at least 231 of which are known autoAgs. Comparing with available COVID data, 352 proteins of the autoantigen-ome have thus far been found to be altered at protein or RNA levels in SARS-CoV-2 infection, 210 of which are known autoAgs. The COVID-altered proteins are significantly associated with RNA metabolism, translation, vesicles and vesicle transport, cell death, supramolecular fibrils, cytoskeleton, extracellular matrix, and interleukin signaling. They offer clues to neurological problems, fibrosis, smooth muscle dysfunction, and thrombosis. In particular, 150 altered proteins are related to the nervous system, including axon, myelin sheath, neuron projection, neuronal cell body, and olfactory bulb. An association with the melanosome is also identified. The findings from our study illustrate a connection between COVID infection and autoimmunity. The vast number of COVID-altered proteins with high intrinsic propensity to become autoAgs offers an explanation for the diverse autoimmune complications in COVID patients. The variety of autoAgs related to mRNA metabolism, translation, and vesicles suggests a need for long-term monitoring of autoimmunity in COVID. The COVID autoantigen atlas we are establishing provides a detailed molecular map for further investigation of autoimmune sequelae of the pandemic, such as “long COVID” syndrome. SUMMARY SENTENCE: An autoantigen-ome by dermatan sulfate affinity from human lung HFL1 cells may explain neurological and autoimmune manifestations of COVID-19. The emergence of the novel coronavirus SARS-CoV-2 has dragged the world into a prolonged pandemic. Aside from the intensively studied ACE2, heparan sulfate is another crucial entry receptor for coronaviruses (1) . Dermatan sulfate (DS), structurally and functionally similar to heparan sulfate and heparin, belongs to the glycosaminoglycan family. Many viruses, including Ebola, Vaccinia, Zika, Dengue, and Hepatitis C viruses, have been shown to interact with glycosaminoglycans (2) (3) (4) (5) . These polyanionic polysaccharides consist of disaccharide repeating units of amino sugars and uronic acids with varying degrees of sulfation. Glycosaminoglycans are major components of the extracellular matrix and basement membrane, act as a filler between cells and tissue fibers and have numerous biological functions. DS is most abundant in the skin but is also found in lungs, blood vessels, heart valves, and tendons. DS plays important roles in cell death, wound healing, and tissue repair. In human wound fluid, DS is the most abundant glycosaminoglycan (6) . Its biosynthesis is increased by fibroblasts, epithelial cells, and capillary endothelial cells in wounded skin, mucosal ulcers, and inflammation-associated angiogenesis (7) (8) (9) . Its molecular size also changes during wound healing, with elongated DS polymers packing along thin collagen fibrils in wounded skin (10) . After tissue injury, fibroblasts require DS to migrate from the stroma surrounding the injury into the fibrin-laden wound to facilitate granulation tissue formation and wound healing (11) . DS is also a key molecule in autoimmunity, as we have discovered (12) (13) (14) (15) (16) . DS is the most potent among glycosaminoglycans in stimulating autoreactive B1 cells and autoantibody production (12, 13) . DS has a peculiar affinity to apoptotic cells and their released autoantigens (autoAgs), and macromolecular autoAg-DS affinity complexes are capable of engaging autoBCRs in a dual signaling event to activate B1 cells (13, 14) . Recently, we also found that DS may steer autoreactive B1 cell fate at the pre-B stage by regulating the immunoglobulin heavy chain of the precursor BCR (17) . Our studies illustrate a unifying property of autoAgs, i.e., self-molecules with DS affinity have a high propensity to become autoAgs, which explains how seemingly unrelated self-molecules can all induce humoral autoimmunity via similar immunological signaling events. In support of our hypothesis and by using DS affinity, we have cataloged hundreds of classic and novel autoAgs (14) (15) (16) 18) . A diverse spectrum of autoimmune symptoms has been observed in COVID-19 patients, including autoimmune cytopenia, multisystem inflammatory syndrome in children, immune-mediated neurological syndromes, Guillain-Barreś yndrome, connective tissue disease-associated interstitial lung disease, antiphospholipid syndrome, autoimmune hemolytic anemia, autoimmune encephalitis, systemic lupus erythematosus, optic neuritis and myelitis, and acquired hemophilia (19) (20) (21) (22) (23) (24) (25) (26) . Many autoantibodies have been identified in COVID patients, including ANA (antinuclear antibody), ENA (extractable nuclear antigen), ANCA (anti-neutrophil cytoplasmic antibody), lupus anticoagulant, antiphospholipid, anti-IFN, anti-myelin oligodendrocyte glycoprotein, and anti-heparin-PF4 complex (19) (20) (21) (22) (23) (24) (25) (26) (27) . To understand autoimmune sequelae of COVID, we aimed to establish a COVID autoantigen atlas that will serve as a molecular map to guide ongoing research into autoimmune sequelae of COVID (such as "long COVID" syndrome) and vaccine evaluation. Acute COVID leads to significant acute inflammatory lung injury and histologic remodeling that involves marked lung fibroblast activation and cell turnover (28) . In this study, we identified an autoantigen-ome of 408 proteins from human fetal lung fibroblast HFL1 cells by DSaffinity fractionation and protein sequencing, with at least 231 being known autoAgs. We then compared these with currently available data from SARS-CoV-2-infected patients and cells (as of 12/14/2020 in Coronascape) . Remarkably, 352 (86.3%) of these proteins have been found to be altered (up-or down-regulated) at protein and/or RNA expression levels, and 210 of the COVID-altered proteins are known autoAgs in a great variety of autoimmune diseases and cancers. The COVID-altered proteins reveal intricate host responses to the viral infection and point to close associations with diverse disease manifestations of COVID-19. An Autoantigen-Ome of 408 Proteins With DS-Affinity From HFL1 Cells Proteins extracted from HFL1 cells were fractionated with DSaffinity resins. The DS-binding fraction eluting with 0.5 M NaCl yielded 306 proteins by mass spectrometry sequencing, corresponding to proteins with medium-to-strong DS affinity. The fraction eluting with 1.0 M NaCl yielded 121 proteins, corresponding to proteins with very strong DS affinity. After excluding redundancies, a total of 408 unique proteins were obtained ( Table 1) . To verify how many of these proteins are known autoAgs, we conducted an extensive literature search for autoantibodies specific for each protein. Remarkably, at least 231 (57%) of our DS-affinity proteins already have known associated specific autoantibodies in various diseases and are thus confirmed autoAgs, corresponding to 61% of proteins with very strong DS affinity and 54% of proteins with medium-tostrong DS affinity (see references in Table 1) . Of those not yet confirmed as autoAgs, a majority are similar to known autoAgs. As an example, we identified 18 ribosomal proteins, of which 9 have been individually identified as autoAgs ( Table 1) ; however, anti-ribosomal autoantibodies are reported to react with a heterogeneous pool of many ribosomal proteins (206) . Therefore, many of the ribosomal proteins we identified may be true but yet-to-be-confirmed autoAgs. As another example, autoantibodies against the 20S proteasome core are reported to be polyspecific and react with many subunits (250) . Thus, although only 7 of 15 proteasome proteins we identified are thus far individually confirmed, the remainder may be true but yet-to-be-specified autoAgs. Similarly, some members of LGALS1 eukaryotic translation initiation and elongation factors are confirmed autoAgs, while others await confirmation. In summary, the putative autoantigen-ome from HFL1 cells provides at least 231 confirmed and 177 yet-to-confirm putative autoAgs ( Table 1) . To find out whether DS-affinity-associated proteins are a random collection or biologically connected, we performed protein-protein interaction analyses with STRING (251) . Of the 408 DS-associated proteins, 405 proteins recognized by STRING (ANP32C, ANXA2P2, HSP90AA2 excluded) have 7,582 interactions, whereas a random set of 405 proteins is expected to have only 3,060 interactions; hence, DS-affinity proteins represent a significantly connected network with PPI enrichment p-value <1.0E-6 ( Figure 1 ). Based on cellular component classification, these proteins are highly concentrated in the nucleus (226 proteins), vesicles (111 proteins), ribonucleoprotein complexes (95 proteins), and the cytoskeleton (95 proteins). Pathway and process analyses by STRING and Metascape (29) revealed that the mRNA metabolic process is the most enriched GO Biological Process, and the top KEGG pathways are the spliceosome and protein processing in the endoplasmic reticulum. The top Reactome pathways are metabolism of RNA, metabolism of proteins, and axon guidance. The top local network clusters are GTP hydrolysis and joining of the 60S ribosomal subunits and mRNA splicing. The Molecular Complex Detection algorithm identified clusters related to eukaryotic translation elongation, cellular responses to stress, regulation of RNA stability, COPI-independent Golgi-to-ER retrograde traffic, and supramolecular fiber organization. To find out which autoAgs may be involved in COVID-19, we compared the DS-affinity autoantigen-ome with proteins and genes that are up-or down-regulated in SARS-CoV-2 infection (Coronascape database comparison, Supplementary Table 1 ) . Remarkably, 352 (86.3%) of the 408 DS-affinity proteins have been found to be altered (up-and/or down-regulated at protein and/or mRNA levels) in COVID-19 patients or SARS-CoV-2 infected cells ( Table 1) . Of these, 260 are reported as upregulated and 303 as down-regulated (including 211 that are both up-and down-regulated). The numbers are not conflicting, because the COVID data were generated by multiple proteomic and transcriptomic methods and different cells and tissues. A protein may not be overexpressed even when its mRNA is upregulated, and a protein/gene may be up-regulated in one tissue or patient but down-regulated in another tissue or patient. A protein is considered altered if it is up-or down-regulated at the protein or RNA level and, in relation to SARS-CoV-2 infection, it is considered a COVID-altered protein. Protein-interaction analysis revealed that 352 COVID-altered proteins form a highly connected network, exhibiting 6,286 interactions (vs. 2,451 expected; PPI enrichment p-value <1.0E-6) ( Figure 2 ). Based on cellular component analysis, the altered proteins can be located to intracellular organelles (323 proteins), nucleus (199 proteins Similarly, the group of 260 up-regulated proteins is highly connected (3,747 interactions vs. 1,424 expected) with significant enrichment in proteins associated with RNA and mRNA metabolism, translation, vesicles and vesicle-mediated transport, and regulation of cell death ( Figure 3A) . The group of 303 down-regulated proteins is also highly connected (4,860 interactions vs. 1,907 expected), and these proteins are significantly related to RNA metabolism, translation, vesicles, cytoskeleton, and extracellular matrix ( Figure 3B ). Network enrichment analysis by Metascape revealed that the 352 COVID-altered proteins are most significantly enriched in RNA metabolism, axon guidance, and translation ( Table 2 ). Many processes, e.g., regulated exocytosis, wound healing, supramolecular fiber organization, smooth muscle contraction, and platelet degranulation are significantly affected by COVID-altered proteins regardless of whether they are up-or down-regulated. The upregulated proteins are more related to axon guidance and interleukin signaling, whereas down-regulated proteins are more related to cellular response to stress and apoptosis. COVID-19 patients frequently report neurological problems, such as loss of smell and taste, dizziness, headache, and stroke. While most symptoms are transient, some recovered patients are haunted by lingering neurological and psychological problems long after the viral infection. The underlying cause of transient and long-lasting neurological effects of COVID-19 has been puzzling. Analysis of COVID-altered proteins revealed a strong link to the nervous system. Of the 352 COVID-altered proteins, at least 150 are related to the nervous system ( Figure 4A ). More than 60 proteins are related to axon guidance based on ontology analyses ( Table 2 and Figure 4A ). In addition, there are 39 proteins related to neuron projection, 26 proteins related to myelin sheath, 25 proteins related to axon growth cone (252), 16 proteins related to neuronal cell body, 4 proteins related to cerebellar Purkinje cell layer, 3 proteins related to peripheral nervous system axon regeneration, and 2 proteins related to radial glial scaffolds. In particular, we found that 23 COVID-altered proteins are related to the olfactory bulb (253) , which may explain the loss of smell in many COVID-19 patients. Most of these proteins are known autoAgs, e.g., ACTB, CANX, A2M, APOA1, CAPZA1, DPYSL2, FLNA, GDI2, LGALS1, MSN, PDIA3, PFN2, TNC, UCHL1, VCP, and VCL (see autoAg references in Table 1) . Some yet-to-be-confirmed autoAgs with direct relation to the nerve system, e.g., NES (expressed mostly in nerve cells) and APOD (expressed by oligodendrocytes), warrant further investigation. The COVID-altered proteins are also associated with a number of neurological diseases ( Figure 4B ). By comparing our data with published proteomes, 23 proteins were similarly found in neuronal infection by Japanese encephalitis virus (254) Coronavirus-induced demyelination has been reported in a mouse model of multiple sclerosis (262) , which may explain our identification of 26 altered proteins related to the myelin sheath in SARS-CoV-2 infection. In a mouse brain injury model, DS appears to play an important role in glial scar formation and regeneration of dopaminergic axons (263) . Alterations of white matter DS and extracellular matrix are specific, dynamic, and widespread in multiple sclerosis patients (264) . DS has recently been reported to promote neuronal differentiation in mouse and human neuronal stem cells (265) . Given the various functional roles of DS, our identification of a large number of known and putative autoAgs with DS affinity related to the nervous system is a compelling finding. SARS-CoV-2 infection causes host cell death and leads to tissue injury. Wound healing, cellular response to stress, and apoptosis are among the most significant processes related to COVID-altered proteins ( Table 2 and Figure 5A ). For example, we identified 66 proteins related to regulation of cell death and 23 related to regulation of apoptotic signaling pathways. DS binds to apoptotic cells and autoAgs released from dying cells, which has led to our previous identification of hundreds of autoAgs (13) (14) (15) (16) 18) . and epithelial and endothelial cells (7) (8) (9) . After tissue injury, DS assists fibroblast migration into the wound to facilitate granulation tissue formation and wound healing (11) . DS, similar to heparin, is also an important anticoagulant that inhibits clot formation via interaction with antithrombin and heparin cofactor II (266) . Given these biological roles of DS, it is consistent that a large number of COVID-altered proteins related to cell death and tissue injury are identified by DS-affinity. Blood coagulation and thrombosis are frequent complications of COVID-19. Platelet degranulation is found to be significantly associated with at least 18 altered proteins ( Table 2 and Figure 5A ). COVID-altered proteins are related to blood coagulation, platelet activation, platelet alpha granules, fibrinogen binding, fibrinogen complex, platelet plug formation, von Willebrand factor A-like domain superfamily, and platelet-derived growth factor binding. Collagens, which support platelet adhesion and activation, and collagen biosynthesis and modifying enzymes are also among the COVID-altered proteins, e.g., collagen type VI trimer and type I trimer ( Figure 5A ). The majority of these altered proteins are known autoAgs, e.g., ALB, ANXA5, C1QBP, CALM1, CAPZB, COL1A1, COL1A2, COL6A1, FBLN1, FN1, PLEC, PPIB, THBS1, TLN1, TUBA4A, and YWHAZ (see autoAg references in Table 1 ). Some are unknown and await further investigation, e.g., AP3B1, CRK, CTSB, EHD2, PLOD1, PSAP, and PARKAR2A. Over 50 supramolecular filament proteins are identified by DSaffinity from HFL1 cells. Remarkably, nearly all (except for one) are found to be altered in SARS-CoV-2 infection, and the majority have already been reported as autoAgs ( Table 1) . They include various isoforms of actin, actinin, collagen, filamin, fibronectin, fibulin, dynactin, dynein, lamin, myosin, nestin, nexilin, profilin, plectin, plastin, proteoglycan, septin, spectrin, talin, tropomyosin, tubulin, vinculin, and vimentin (Table 1 and Figure 5B ). These proteins are major components of the extracellular matrix, basement membrane, cell cytoskeleton, cytoskeletal motors, muscle filaments, and contractile motors of muscle cells. A significant number of COVID-altered proteins are related. Emerin complex and smooth muscle contraction are among the top enriched biological processes of COVID-altered proteins ( Table 2 and Figure 5B ). Emerin is highly expressed in cardiac and skeletal muscle, and emerin mutations cause X-linked recessive Emery-Dreifuss muscular dystrophy, cardiac conduction abnormalities, and dilated cardiomyopathy. Smooth muscle resides primarily in the walls of hollow organs where it performs involuntary movements, e.g., respiratory tract, blood vessels, gastrointestinal tract, and renal glomeruli. In addition, we identified proteins with significant association to myofibrils (the contractile elements of skeletal and cardiac muscle; 23 proteins) ( Figure 5B) , stress fiber (a contractile actin filament bundle that consists of short actin filaments with alternating polarity: MYH9, MYLK, FLNB, TPM1, TPM2, TPM3, TPM4, ACTN1, ACTN4), muscle filament sliding (the sliding of actin thick filaments and myosin thick filaments past each other in muscle contraction), Z disk (plate-like region of a muscle sarcomere to which the plus ends of actin filaments are attached), intercalated disc (a cell-cell junction complex at which myofibrils terminate in cardiomyocytes, mediates mechanical and electrochemical integration between individual cardiomyocytes), and negative regulation of smooth muscle cell-matrix adhesion (2 proteins; SERPINE1, APOD). Pulmonary fibrosis is prominent in COVID-19 and contributes to lethality in some cases (267, 268) . Fibrosis, or fibrotic scarring, is pathological wound healing in which excessive extracellular matrix components are produced by fi brobl asts and a ccumulate in the wounded area. Histopathological examination of COVID-19 patients found highly heterogenous injury patterns reminiscent of exacerbation of interstitial lung disease, including interstitial thickening, fibroblast activation, and deposition of collagen fibrils (22) . We identified a significant number of COVIDaltered proteins that are associated with collagen bundles and collagen biosynthesis and modifying enzymes (16 proteins), extracellular matrix organization (33 proteins), supramolecular fibers, and amyloid formation offering functional links to fibrosis ( Figure 5B ). To find out how altered proteins may differ in patients, we compared our putative autoantigen-ome to published single-cell RNA sequencing data of 6 patients hospitalized for COVID-19 (29, 35) and identified 32-59 putative autoAgs per patient ( Figure 6) . Interestingly, while identified from different patients, the altered proteins/genes identified share involvement of leukocyte activation, vesicles and vesicle transport, protein processing in the ER (including antigen processing and presentation), regulation of cell death, translation, muscle contraction, myelin sheath, and curiously, the melanosome ( Figure 6 ). The estrogen signaling pathway and thyroid hormone synthesis are found to be associated with altered proteins in some patients. Patient C2 has 5 altered proteins related to neuron differentiation regulation, and patient C4 has 6 altered proteins related to neuron death. Eleven altered proteins were identified in all 6 patients, including known autoAgs (ACTB, EEF1A1, EEF2, ENO1, LGALS1, PABPC1) and unknown ones (CRTAP, NAP1L1, PSAP, RRBP1, TPT1) ( Table 1) . AHNAK (neuroblast differentiation-associated protein, a known autoAg in lupus) was identified in 5 patients. Overall, a majority of the altered proteins identified from the 6 COVID patients are known autoAgs, e.g., CALM1, CALR, CALU, CANX, DNAJB11, HDGF, HSPA5 (BiP), IQGAP1, LCP1, LMNB1, MYH9, NACA, P4HB, SFPQ, PDIA3, TPM3, TUBB, VCP, VIM, WARS, and YB3 ( Table 1) . Unknown or putative autoAgs include CAP1, CTSB, HDLBP, HYOU1, SND1, and SUB1. We initially identified 30 DS-affinity proteins from HFL1 cells related to the melanosome, and, intriguingly, all of these are also COVID-altered proteins ( Figure 5B ). Based on STRING GO analysis, the melanosome is the most significant cellular component related to altered proteins in all 6 patients (with false discovery rates ranging from 1.52E-8 to 1.11E-23). In HIV infection, melanosome production is stimulated in some patients and leads to an increase in pigmented lesions (269) . However, melanosome involvement in COVID-19 is not known. Two Wuhan doctors in intensive care for COVID temporally turned dark, although the cause was thought to be a drug reaction. A COVID patient has been reported with acute flaccid tetraparesis and maculopapular pigmented plaques on the limbs (270) . In mice, coronavirus induces an acute and long-lasting retinal disease, with initial retinal vasculitis followed by retinal degeneration that is associated with retinal autoantibodies and retinal pigment epithelium autoantibodies (271) . Future research will be needed to investigate the interaction between COVID and melanosome activation. We identified COVID-altered proteins with DS-affinity that are involved in the host response to various aspects of viral infection and that possess a high propensity to become autoAgs. For example, viral RNA metabolism, translation, vesicles, and vesicle transport contribute a large number of known and putative autoAgs. In addition, viral processes, particularly symbiont processes and interspecies interactions between host and viruses, contribute significantly to altered proteins ( Figure 7A ). For example, among altered proteins related to response to viral processes, HSPA8, DDB1, RAD23A, PABPC1, PPIB, P4HB, LGALS1, GSN, and ILF3 are known autoAgs ( Table 1) . In particular, COVID-altered cytoskeletal filament proteins shed light on viral trafficking in host cells. SARS-CoV-2 infection induces profound remodeling of the cytoskeleton, and replicating viral vesicles are surrounded by a network of intermediate filaments (272) . The cytoskeletal network appears to facilitate coronavirus transport and expulsion, with thickening actin filaments providing the bending force to extrude viral vesicles (273) . We identified 84 altered proteins related to the cytoskeleton and 84 altered proteins related to vesicle-mediated transport ( Figure 2) . These altered proteins are implicated in various processes, including cytoskeleton-dependent intracellular transport, actin fiber-based movement, actin-mediated cell contraction, microtubuledependent trafficking from the Golgi to the plasma membrane, and transport along microtubules. Many positive-strand RNA viruses (including SARS-CoV-2, Enterovirus, Hepatitis C virus, Norovirus, and Poliovirus) hijack a common group of nuclear factors to support the biosynthetic functions required for viral replication and propagation (274) . 20 of these hijacked nuclear proteins are identified by DS-affinity in our study (Figure 7 ). In addition, altered proteins are found in other viral infections, including porcine reproductive and respiratory syndrome virus (275) , H5N1 avian influenza viruses (276, 277) Figure 7B and STRING ontology analysis). In some cases, viral infections may have both enhancing and protective effects on autoimmunity in type 1 diabetes (284) . Our study identified a large number of known and putative autoAgs that are related to mRNA metabolism, translation, vesicles, and vesicle trafficking (Figures 1, 2) . This finding begs us to wonder whether mRNA vaccines may induce unintended autoimmune consequences in the long term. To induce protective immunity, mRNA vaccine vesicles will need to be transported into cells where they use the host cell machinery to produce a viral protein antigen, whereupon the antigen will be processed and presented by MHC molecules to induce B and T cell responses. mRNA translation requires ribosomes, translation initiation factors, aminoacyl-tRNA synthetases, and elongation factors. We identified 18 ribosomal proteins by DS-affinity, all of which are altered in SARS-CoV-2 infection and 9 of which are known autoAgs (see references in Table 1 ). We also identified 15 eukaryotic translation initiation factor proteins, with 12 of them being COVID-altered and 4 being known autoAgs ( Table 1) . Six elongation factor proteins (5 subunits of EEF1 complex, EEF2) were identified by DS-affinity, of which all 6 are COVID-altered and 3 are known autoAgs ( Table 1) . Six tRNA synthetases were identified, with 5 being known autoAgs and 3 (AARS, EPRS, WARS) COVID-altered ( Table 1) . Autoantibodies to AARS are associated with interstitial lung disease and myositis (51, 285) . EPRS appears to regulate pro-fibrotic protein synthesis during cardiac fibrosis (286) . Gene mutations of WARS cause an autosomal dominant neurologic disorder characterized by slowly progressive distal muscle weakness and atrophy affecting both the lower and upper limbs (242, 287) . Once synthesized, the exogenous protein antigens are degraded by proteasomes, and the resulting peptides are transported into the ER where they are loaded onto MHC molecules by peptide loading complexes for presentation to T cells. In relation to these steps, 15 proteasome subunits were identified by DS-affinity, with 12 being COVID-altered and 7 being known autoAgs ( Table 1) . Nine proteins related to antigen processing and presentation are found to be altered in the 6 COVID-19 patients analyzed in this study, including HSPA1A, HSPA8, HSP90AA1, HSPAB1, HSPA5, PDIA3, CANX, CALR, and CTSB, with 7 being known autoAgs ( Figure 5 and Table 1 ). In addition, among the 352 COVID-altered proteins identified in this study, 69 proteins are associated with mRNA metabolism (Figure 2) . Many of these proteins may be irrelevant to non-replicating mRNA molecules in mRNA vaccines, however, some are likely needed in processes such as 3' end processing, deadenylation, and nonsense-mediated decay. For example, we identified poly(A) tail binding proteins PABPC1 and PABPC4 as COVID-altered proteins, both of which have been reported as autoAgs ( Table 1) . Our study identified 99 altered proteins associated with vesicles and 84 proteins associated with vesicle-mediated transport (Figures 1, 2, 5) . Although it is not clear which host molecules are involved in extra-and intracellular transport and uptake of mRNA vaccine vesicles, some of the vesicle-related proteins identified as DS-affinity proteins may be involved, e.g., proteins of receptor-mediated endocytosis (APOA1, CALR, CANX, CAP1, CLTC, HSP90AA1, HSP90B1, HSPG2, ITGB1, YWHAH) or phagocytosis (ACTB, CRK, GSN, HSP90AA1, HSP90AB1, MYH9, MYO1C, PDIA6, RAB7A, THBS1, TXNDC5) . Overall, a significant number of autoAgs related to different steps of mRNA vaccine action were identified in this study; however, our findings do not mean that these autoAgs will lead to aberrant autoimmune reactions as a result of mRNA vaccination. The development of autoimmune diseases or autoimmunity-related diseases entails a complex cascade of molecular and cellular interactions. Long-term monitoring of autoimmune adverse effects will be needed. This study identifies an autoantigen-ome of 408 proteins from human fetal lung fibroblast HFL1 cells by DS-affinity and protein sequencing, of which at least 231 proteins are confirmed autoAgs. Of these, 352 (86.3%) are found to be altered in SARS-CoV-2 infection when compared to published data, with at least 210 COVID-altered proteins being known autoAgs. The altered proteins are significantly enriched in a number of pathways and processes and are closely connected to various disease manifestations of COVID-19, particularly neurological problems, fibrosis, muscle dysfunction, and thrombosis. Viral infections cause significant perturbations of normal cellular and tissue component molecules in the host, leading to cell death and tissue injury. Autoantigens resulting from molecular alterations may result directly from the injury or indirectly from responses to the injury. As a stress response, DS biosynthesis may be ramped up to facilitate wound healing and dead cell clearance. DS associates with autoAgs and stimulates autoreactive B cells and autoantibody production. Specific autoantibodies that are initially induced in response to a certain injury site may circulate and attack secondary sites where the autoAgs are also expressed, leading to a complex array of local and systemic autoimmune diseases. This study supports a connection between COVID and autoimmunity. We have shown in a series of papers on autoimmune disease that proteins with high affinity for DS possess intrinsic propensity to become recognized by the humoral immune system and serve as autoantigens (12) (13) (14) (15) (16) 18) . We have shown in a prior paper that proteins that are, by themselves, not immunogenic can be turned into potent autoantigens and induce an autoantibody response if they are engineered to bind to DS and are exposed as DS-autoAg complexes to the immune system (14) . The list of proteins enriched by DS-affinity in lung fibroblasts is, at first, only a putative catalogue of autoantigens. Intriguingly, when we performed a literature analysis of all DS-enriched proteins, we found that a very high proportion of them correspond to known autoantigens (this enrichment is much higher than would be expected by chance). Many of the COVID-induced autoantibodies described in a recent study correspond to autoantigens identified in our study (e.g., ribosomal P proteins, Ro/La, U1-snRNP, and chromatin histones) (288) . While likely also autoantigens, we label proteins that have not been observed as autoantigens in the literature as "putative autoAgs." We then show that among the DS-affinity proteins, there are many proteins that are also affected by COVID (many more than would be expected by statistical chance). Taking all these observations together, we hypothesize that our findings provide a rationale for why SARS-CoV-2 infection may induce autoimmune sequelae. Future serological studies will be needed to further confirm this hypothesis, but our dataset, together with the comprehensive list of possible autoAg targets, will be a valuable guide and map for these ongoing investigations. We believe that our dataset will be of great interest and value for research groups worldwide that are attempting to tackle the autoimmune aspects of COVID. The COVID-19 autoantigen-ome provides a detailed molecular map for investigating the diverse spectrum of autoimmune sequelae caused by the pandemic. The COVID autoantigen atlas we are establishing will serve as a detailed molecular map and reference for ongoing research into COVIDinduced autoimmunity and possible autoimmune causes of "long COVID" syndrome. It will thus serve as an important resource for the scientific community. The HFL1 cell line was obtained from the ATCC (Manassas, VA, USA) and cultured in Eagle's Minimum Essential Medium supplemented with 10% fetal bovine serum (Thermo Fisher) and a penicillin-streptomycin-glutamine mixture (Thermo Fisher) at 37°C. About 100 million cells were harvested and suspended in 10 ml of 50 mM phosphate buffer (pH 7.4) containing the Roche Complete Mini protease inhibitor cocktail. Cells were homogenized on ice with a microprobe sonicator until the turbid mixture became nearly clear with no visible cells left. The homogenate was centrifuged at 10,000 g at 4°C for 20 min, and the supernatant was collected as the total protein extract. Protein concentration was measured with the RC DC protein assay (Bio-Rad). The total proteins extracted from HFL1 cells were fractionated on DS-Sepharose columns with a BioLogic Duo-Flow system (Bio-Rad). About 40 mg of proteins in 40 ml of 10 mM phosphate buffer (pH 7.4; buffer A) were loaded onto the column at a rate of 1 ml/min. Unbound proteins were washed off with 60 ml of buffer A, and weakly bound proteins were eluted with 40 ml of 0.2 M NaCl in buffer A. DS-binding proteins were eluted with sequential 40-ml step gradients of 0.5 M and 1.0 M NaCl in buffer A. Fractions were desalted and concentrated to 0.5 ml with 5-kDa cut-off Vivaspin centrifugal filters (Sartorius). Fractionated proteins were separated by 1-D SDS-PAGE in 4-12% Bis-Tris gels, and the gel lanes corresponding to 1.0 M or 0.5 M NaCl elutions were divided into two or three sections for sequencing. Fractionated proteins with different affinity to DS were separated on 1D SDS PAGE in 4-12% NuPAGE Novex Bis-Tris gels (Invitrogen). Based on protein band intensity, the protein lanes containing proteins eluting at 0.5 M or 1.0 M NaCl were each cut into 2 sections, containing top and bottom bands, respectively. Gel sections were transferred into 1-mL tubes, cut into 1-mm 3 pieces, dehydrated with acetonitrile, and dried in a speed-vac. Protein sequencing was performed at the Taplin Biological Mass Spectrometry Facility at Harvard Medical School. The gel pieces were rehydrated with 50 mM NH 4 HCO 3 containing 12.5 µg/mL modified sequencing-grade trypsin (Promega) at 4°C for 45 min. Tryptic peptides were separated on a nano-scale C 18 HPLC capillary column and analyzed after electrospray ionization in an LTQ linear ion-trap mass spectrometer (Thermo Fisher). The reference human proteome database was downloaded from UniProt (updated until March 2021). Peptide sequences and protein identities were assigned by matching the measured fragmentation patterns with protein or translated nucleotide databases using Sequest software. Peptides were required to be fully tryptic peptides with XCorr values of at least 1.5 for 1+ ions, 1.5 for 2+ ions, or 3.0 for 3+ ions. All data were manually inspected. Only proteins with ≥2 unique peptide matches were considered positively identified using a false discovery rate of <1% at peptide and protein levels (Supplemental Table 2 ). DS-affinity proteins were compared with currently available proteomic and transcriptomic data from SARS-CoV-2 infection compiled in the Coronascape database (as of 12/14/ 2020) . These data had been obtained with proteomics, phosphoproteomics, interactome, ubiquitome, and RNA-seq techniques. Up-and down-regulated proteins or genes were identified by comparing COVID-19 patients vs. healthy controls and cells infected vs. uninfected by SARS-CoV-2. Similarity searches were conducted between our data and the Coronascape database to identify DS-affinity proteins (or their corresponding genes) that are up-and/or down-regulated in the viral infection. Pathways and processes enriched in the putative autoantigenome were analyzed with Metascape (29) . The analysis was performed with various ontology sources, including KEGG Pathway, GO Biological Process, Reactome Gene Sets, Canonical Pathways, CORUM, TRRUST, and DiGenBase. All genes in the genome were used as the enrichment background. Terms with a p-value <0.01, a minimum count of 3, and an enrichment factor (ratio between the observed counts and the counts expected by chance) >1.5 were collected and grouped into clusters based on their membership similarities. The most statistically significant term within a cluster was chosen to represent the cluster. Pathway hierarchical clustering was obtained with ShinyGo (289). Protein-protein interactions among collections of DS-affinity proteins were analyzed by STRING (251), including both direct physical interaction and indirect functional associations. Interactions are derived from genomic context predictions, highthroughput lab experiments, co-expression, automated text mining, and previous knowledge in databases. Each interaction is annotated with a confidence score from 0 to 1, with 1 being the highest, indicating the likelihood of an interaction to be true. Only interactions with high confidence (a minimum score of 0.7) are shown in the figures. Literature searches in Pubmed were performed for every DS-affinity protein identified in this study. Search keywords included the protein name, its gene symbol, alternative names and symbols, and the MeSH keyword "autoantibodies". Only proteins with their specific autoantibodies reported in PubMed-listed journal articles were considered "confirmed" autoAgs in this study. The original contributions presented in the study are included in the article or the Supplementary Material. Further inquiries can be directed to the corresponding authors. JW directed the study, analyzed data, and wrote the manuscript. WZ performed some experiments and reviewed the manuscript. VR and MWR assisted in data analysis and manuscript preparation. MHR consulted on the study, analyzed data, and edited the manuscript. All authors contributed to the article and approved the submitted version. MHR acknowledges grants from the NIH/NCI (R21 CA251992 and R21 CA263262), a Cycle for Survival Equinox Innovation Grant, an Investigator Grant from the Neuroendocrine Tumor Research Foundation (NETRF), and support from the Farmer Family Foundation. Parts of the study were supported by the MSKCC NCI Cancer Center Support Grant (P30 CA008748). The funding bodies were not involved in the design of the study or the collection, analysis, or interpretation of data. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 Heparan Sulfate Is an Important Mediator of Ebola Virus Infection in Polarized Epithelial Cells A Genome-Wide Haploid Genetic Screen Identifies Heparan Sulfate-Associated Genes and the Macropinocytosis Modulator TMED10 as Factors Supporting Vaccinia Virus Infection Role of Heparan Sulfate in the Zika Virus Entry, Replication, and Cell Death Characterization of Hepatitis C Virus Interaction With Heparan Sulfate Proteoglycans Dermatan Sulfate Released After Injury Is a Potent Promoter of Fibroblast Growth Factor-2 Function Expression of Decorin and Biglycan in Rat Gastric Tissue: Effects of Ulceration and Basic Fibroblast Growth Factor Decorin is Produced by Capillary Endothelial Cells in Inflammation-Associated Angiogenesis Dermatan Sulfate Proteoglycan and Glycosaminoglycan Synthesis Is Induced in Fibroblasts by Transfer to a Three-Dimensional Extracellular Environment Size Control of Decorin Dermatan Sulfate During Remodeling of Collagen Fibrils in Healing Skin Fibroblast Invasive Migration Into Fibronectin/Fibrin Gels Requires a Previously Uncharacterized Dermatan Sulfate-CD44 Proteoglycan Glycosaminoglycans Are a Potential Cause of Rheumatoid Arthritis Dermatan Sulfate Interacts With Dead Cells and Regulates CD5(+) B-Cell Fate: Implications for a Key Role in Autoimmunity Human Proteins With Affinity for Dermatan Sulfate Have the Propensity to Become Autoantigens A Comprehensive Autoantigen-Ome of Autoimmune Liver Diseases Identified From Dermatan Sulfate Affinity Enrichment of Liver Tissue Proteins A Repertoire of 124 Potential Autoantigens for Autoimmune Kidney Diseases Identified by Dermatan Sulfate Affinity Enrichment of Kidney Tissue Proteins Dermatan Sulfate Is a Potential Master Regulator of IgH via Interactions With Pre-BCR, GTF2I, and BiP ER Complex in Pre-B Lymphoblasts A Proteomic Repertoire of Autoantigens Identified From the Classic Autoantibody Clinical Test Substrate HEp-2 Cells Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19 Lupus Anticoagulant and Abnormal Coagulation Tests in Patients With Covid-19 Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C) Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD) High Levels of Anti-SSA/Ro Antibodies in COVID-19 Patients With Severe Respiratory Failure: A Case-Based Review : High Levels of Anti-SSA/Ro Antibodies in COVID-19 Detection of Anti-Heparin-PF4 Complex Antibodies in COVID-19 Patients on Heparin Therapy Autoantibodies Against Type I IFNs in Patients With Life-Threatening COVID-19 A Therapeutic Non-Self-Reactive SARS-CoV-2 Antibody Protects From Lung Pathology in a COVID-19 Hamster Model The Spatial Landscape of Lung Pathology During COVID-19 Progression Metascape Provides a Biologist-Oriented Resource for the Analysis of Systems-Level Datasets Single-Cell Landscape of Immunological Responses in Patients With COVID-19 Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection Proteomics of SARS-CoV-2-Infected Host Cells Reveals Therapy Targets A Single-Cell Atlas of the Peripheral Immune Response in Patients With Severe COVID-19 In Vivo Antiviral Host Transcriptional Response to SARS-CoV-2 by Viral Load, Sex, and Age Discovery of SARS-CoV-2 Antiviral Drugs Through Large-Scale Compound Repurposing The Global Phosphorylation Landscape of SARS-CoV-2 Infection Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 Proteomic and Metabolomic Characterization of COVID-19 SARS-CoV-2 Productively Infects Human Gut Enterocytes A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug Repurposing Transcriptomic Characteristics of Bronchoalveolar Lavage Fluid and Peripheral Blood Mononuclear Cells in COVID-19 Patients Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures Dysregulation in Akt/mTOR/HIF-1 Signaling Identified by Proteo-Transcriptomics of SARS-CoV-2 Infected Cells Multi-Level Proteomics Reveals Host-Perturbation Strategies of SARS-CoV-2 and SARS-CoV Transcriptomic Profiling of SARS-CoV-2 Infected Human Cell Lines Identifies HSP90 as Target for COVID-19 Urine Proteome of COVID-19 Patients Single-Cell Landscape of Bronchoalveolar Immune Cells in Patients With COVID-19 Alterations in Antibody Subclass Immune Reactivity to Trophoblast-Derived Fetal Fibronectin and a2-Macroglobulin in Women With Recurrent Pregnancy Loss Autoantibodies Against alanyl-tRNA Synthetase and Trnaala Coexist and are Associated With Myositis Identification and Validation of Candidate Biomarkers Involved in Human Ovarian Autoimmunity The Rheumatoid Arthritis Synovial Fluid Citrullinome Reveals Novel Citrullinated Epitopes in Apolipoprotein E, Myeloid Nuclear Differentiation Antigen, and Beta-Actin Glomerular Antibodies in Lupus Nephritis Tumor-Associated Autoantibodies Are Useful Biomarkers in Immunodiagnosis of a-Fetoprotein-Negative Hepatocellular Carcinoma Identification of AHNAK as a Novel Autoantigen in Systemic Lupus Erythematosus Comparison of Candidate Serologic Markers for Type I and Type II Ovarian Cancer Autoantibodies Targeting Glomerular Annexin A2 Identify Patients With Proliferative Lupus Nephritis Annexin A5 and Anti-Annexin Antibodies in Patients With Systemic Lupus Erythematosus A Case of Neonatal Lupus Erythematosus Presenting Delayed Dilated Cardiomyopathy With Circulating Autoantibody to Annexin A6 Other Antibodies, Diagnostic Pitfalls, Summary and Outlook Autoantibodies to Apolipoprotein A-1 as a Biomarker of Cardiovascular Autoimmunity Auto-Antibodies to b-F1-ATPase and Vimentin in Malignant Mesothelioma Elevated Levels of Synovial Fluid Antibodies Reactive With the Small Proteoglycans Biglycan and Decorin in Patients With Rheumatoid Arthritis or Other Joint Diseases Identification of Cell Surface Straight Chain Poly-N-Acetyl-Lactosamine Bearing Protein Ligands for VH4-34-Encoded Natural IgM Antibodies Autoantigens in the Trabecular Meshwork and Glaucoma-Specific Alterations in the Natural Autoantibody Repertoire The Systemic Lupus Erythematosus (SLE) Disease Autoantigen-Calreticulin can Inhibit C1q Association With Immune Complexes Identification of Target Antigens of Antifibroblast Antibodies in Pulmonary Arterial Hypertension Antibodies to the Endoplasmic Reticulum-Resident Chaperones Calnexin, BiP and Grp94 in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus Identification of Novel Citrullinated Autoantigens of Synovium in Rheumatoid Arthritis Using a Proteomic Approach Proteomics-Based Identification of Autoantibodies in the Sera of Healthy Chinese Individuals From Beijing Immunological Characterization of Heterochromatin Protein P25beta Autoantibodies and Relationship With Centromere Autoantibodies and Pulmonary Fibrosis in Systemic Scleroderma Proteomic Profiling of Antigens in Circulating Immune Complexes Associated With Each of Seven Autoimmune Diseases Serum Antibody Response to Group II Chaperonin From Methanobrevibacter Oralis and Human Chaperonin CCT The Use of a Novel ELISA Method for Detection of Antibodies Against P63 in Sera From Patients Diagnosed With Oral and/or Genital and Skin Lichen Planus Anti-Retinal Antibodies in Patients With Macular Telangiectasia Type 2 Are There Autoantibodies Reacting Against Citrullinated Peptides Derived From Type I and Type II Collagens in Patients With Rheumatoid Arthritis? Autoantibodies to Types I and IV Collagen and Heart Valve Disease in Systemic Lupus Erythematosus/Antiphospholipid Syndrome Anti-Type II Collagen Antibodies Detection and Avidity in Patients With Oligoarticular and Polyarticular Forms of Juvenile Idiopathic Arthritis Antibodies to Collagen in Patients With Idiopathic Pulmonary Fibrosis Antibodies to K-a 1 Tubulin and Collagen V Are Associated With Chronic Rejection After Lung Transplantation Antihuman Leukocyte Antigen Antibody-Induced Autoimmunity: Role in Chronic Rejection Copa Syndrome: A Novel Autosomal Dominant Immune Dysregulatory Disease Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays Clinical Association of Anti-Golgi Autoantibodies and Their Autoantigens Non-Self-Discrimination as a Driving Concept in the Identification of an Immunodominant HMW-MAA Epitopic Peptide Sequence by Autoantibodies From Melanoma Cancer Patients Autoantibody Profiling as a Diagnostic Marker for Cancers Drebrin Autoantibodies in Patients With Seizures and Suspected Encephalitis Differential Switching to IgG and IgA in Active Smoking COPD Patients and Healthy Controls Molecular Characterization of Two Human Autoantigens: Unique cDNAs Encoding 95-and 160-kD Proteins of a Putative Family in the Golgi Complex Do We Need New Autoantibodies in Lupus? Inhibition of Alpha-Ketoglutarate Dehydrogenase Activity by a Distinct Population of Autoantibodies Recognizing Dihydrolipoamide Succinyltransferase in Primary Biliary Cirrhosis Autoantibody to Heat Shock Protein Hsp40 in Sera of Lung Cancer Patients Identification of Chronic Brain Protein Changes and Protein Targets of Serum Auto-Antibodies After Blast-Mediated Traumatic Brain Injury The Level of Autoantibodies Targeting Eukaryote Translation Elongation Factor 1 a1 and Ubiquitin-Conjugating Enzyme 2L3 in Nondiabetic Young Adults Identification of Autoantibodies Elicited in a Patient With Prostate Cancer Presenting as Dermatomyositis Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer 20S Small Nuclear Ribonucleoprotein U5 Shows a Surprisingly Complex Protein Composition Autoantigens in Vitiligo Identified by the Serological Selection of a Phage-Displayed Melanocyte cDNA Expression Library Serum Anti-EIF3A Autoantibody as a Potential Diagnostic Marker for Hepatocellular Carcinoma Identification of a Novel Autoantigen Eukaryotic Initiation Factor 3 Associated With Polymyositis Augmentation of Autoantibodies by Helicobacter Pylori in Parkinson's Disease Patients May Be Linked to Greater Severity HuR, a Novel Target of Anti-Hu Antibodies, Is Expressed in Non-Neural Tissues Surface Expression of a Glycolytic Enzyme, Alpha-Enolase, Recognized by Autoantibodies in Connective Tissue Disorders Pituitary Autoantibodies in Lymphocytic Hypophysitis Target Both Gamma-and Alpha-Enolase -A Link With Pregnancy? Reaction of Anti-OJ Autoantibodies With Components of the Multi-Enzyme Complex of aminoacyl-tRNA Synthetases in Addition to isoleucyl-tRNA Synthetase Identification of Tumor-Associated Antigens With Diagnostic Ability of Colorectal Cancer by in-Depth Immunomic and Seroproteomic Analysis The Synaptic Vesicle Protein Synaptotagmin Associates With Calcium Channels and is a Putative Lambert-Eaton Myasthenic Syndrome Antigen Identification of Autoantibody Against Fatty Acid Synthase in Hepatocellular Carcinoma Mouse Model and Its Application to Diagnosis of HCC Identification of Breast Cancer-Restricted Antigens by Antibody Screening of SKBR3 cDNA Library Using a Preselected Patient's Serum Identification of Novel Autoantigens via Mass Spectroscopy-Based Antibody-Mediated Identification of Autoantigens (MS-AMIDA) Using Immune Thrombocytopenic Purpura (ITP) as a Model Disease Circulating Anti-Filamin C Autoantibody as a Potential Serum Biomarker for Low-Grade Gliomas Fibronectin Promotes Nasopharyngeal Cancer Cell Motility and Proliferation Combined Measurement of CA 15-3 With Novel Autoantibodies Improves Diagnostic Accuracy for Breast Cancer Detection of Novel Auto-Antigens in Patients With Recurrent Miscarriage: Description of an Approach and Preliminary Findings Anti-GAPDH Autoantibodies as a Pathogenic Determinant and Potential Biomarker of Neuropsychiatric Diseases Identification of the Novel Autoantigen Candidate Rab GDP Dissociation Inhibitor Alpha in Isolated Adrenocorticotropin Deficiency Serological Proteome Analysis (SERPA) as a Tool for the Identification of New Candidate Autoantigens in Type 1 Diabetes Identification of the Thioredoxin-Like 2 Autoantibody as a Specific Biomarker for Triple-Negative Breast Cancer Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach Autoantibodies Associated With Lupus Induced by Diverse Drugs Target a Similar Epitope in the (H2A-H2B)-DNA Complex The Central Role of Chromatin in Autoimmune Responses to Histones and DNA in Systemic Lupus Erythematosus Circulating Auto-Antibody Against Hepatoma-Derived Growth Factor (HDGF) in Patients With Ulcerative Colitis Autoantibodies Against Different Histone H1 Subtypes in Systemic Lupus Erythematosus Sera Antibodies to H2a and H2b Histones From the Sera of HIV-Infected Patients Catalyze Site-Specific Degradation of These Histones Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens Apoptosis-Associated Acetylation on Histone H2B Is an Epitope for Lupus Autoantibodies Antibodies Against H3 and H4 Histones From the Sera of HIV-Infected Patients Catalyze Site-Specific Degradation of These Histones Emergence of Autoantibodies to HMGB1 Is Associated With Survival in Patients With Septic Shock Autoimmunity to Heterogeneous Nuclear Ribonucleoprotein A1 in Psoriatic Patients and Correlation With Disease Severity Antibodies to Native and Citrullinated RA33 (hnRNP A2/B1) Challenge Citrullination as the Inciting Principle Underlying Loss of Tolerance in Rheumatoid Arthritis Multiple Specificities of Autoantibodies Against hnRNP a/B Proteins in Systemic Rheumatic Diseases and hnRNP L as an Associated Novel Autoantigen Heterogeneous Nuclear Ribonucleoproteins C1/C2 Identified as Autoantigens by Biochemical and Mass Spectrometric Methods AUF1, the Regulator of Tumor Necrosis Factor Alpha Messenger RNA Decay, Is Targeted by Autoantibodies of Patients With Systemic Rheumatic Diseases Low Level Antibodies Against Alpha-Tropomyosin Are Associated With Increased Risk of Coronary Heart Disease Heterogeneous Nuclear RNPs as Targets of Autoantibodies in Systemic Rheumatic Diseases Proteomic Identification of Heterogeneous Nuclear Ribonucleoprotein K as a Novel Cold-Associated Autoantigen in Patients With Secondary Raynaud's Phenomenon Molecular Definition of Heterogeneous Nuclear Ribonucleoprotein R (hnRNP R) Using Autoimmune Antibody: Immunological Relationship With hnRNP P Identification of Citrullinated Hsp90 Isoforms as Novel Autoantigens in Rheumatoid Arthritis-Associated Interstitial Lung Disease Type 1 Diabetes Alters Anti-Hsp90 Autoantibody Isotype Anti-Heat Shock Protein 90beta Antibodies Are Detected in Patients With Multiple Sclerosis During Remission Autoimmunity to Endoplasmic Reticulum Chaperone GRP94 in Myasthenia Gravis Anti-HSP70 Autoantibody Formation by B-1 Cells in Toxoplasma Gondii-Infected Mice Glucose-Regulated Protein 78 Autoantibody Associates With Blood-Brain Barrier Disruption in Neuromyelitis Optica Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection From Oxidative Stress and Apoptosis Serum Antibodies to the 27-Kd Heat Shock Protein in Women With Gynecologic Cancers Autoantibodies to the Protein Core of Vascular Basement Membrane Heparan Sulfate Proteoglycan in Systemic Lupus Erythematosus ILF2 and ILF3 Are Autoantigens in Canine Systemic Autoimmune Disease RasGAP-Like Protein IQGAP1 Is Expressed by Human Keratinocytes and Recognized by Autoantibodies in Association With Bullous Skin Disease Importin Beta: A Novel Autoantigen in Human Autoimmunity Identified by Screening Random Peptide Libraries on Phage Identification of Kinectin as a Novel Behcȩt's Disease Autoantigen Pregnancy Loss and Endometriosis: Pathogenic Role of Anti-Laminin-1 Autoantibodies Differential Expression of Laminin Chains and Anti-Laminin Autoantibodies in Experimental Lupus Nephritis Identification of L-Plastin Autoantibody in Plasma of Patients With Non-Hodgkin's Lymphoma Using a Proteomics-Based Analysis Anti-Galectin-1 Autoantibodies in Serum of Patients With Neurological Diseases Autoantibodies to Lamins A and C in Sera of Patients Showing Peripheral Fluorescent Antinuclear Antibody Pattern on HEP-2 Cells High Frequency of Autoantibodies to Insoluble Cellular Antigens in Patients With Chronic Fatigue Syndrome Autoantibodies to Human Nuclear Lamin B2 Protein. Epitope Specificity in Different Autoimmune Diseases Cloning of Novel Soluble Gp130 and Detection of Its Neutralizing Autoantibodies in Rheumatoid Arthritis Microtubule-Associated Protein 1B: Novel Paraneoplastic Biomarker A Novel Autoantibody Against Moesin in the Serum of Patients With MPO-ANCA-Associated Vasculitis Major Vault Protein/Lung Resistance Related Protein: A Novel Biomarker for Rheumatoid Arthritis Non-Muscle Myosin as Target Antigen for Human Autoantibodies in Patients With Hepatitis C Virus-Associated Chronic Liver Diseases Monodisperse Magnetic Poly(Glycidyl Methacrylate) Microspheres for Isolation of Autoantibodies With Affinity for the 46 kDa Form of Unconventional Myo1C Present in Autoimmune Patients Characterization of a Novel Isoform of Alpha-Nascent Polypeptide-Associated Complex as IgE-Defined Autoantigen Analysis of the Autoimmune Epitopes on Human Testicular NASP Using Recombinant and Synthetic Peptides Antibodies Against Nucleolin in Recipients of Organ Transplants Production and Characterization of a Monoclonal Antibody Against the Sialidase of Gardnerella Vaginalis Using a Synthetic Peptide in a MAP8 Format A Distinct Repertoire of Autoantibodies in Hepatocellular Carcinoma Identified by Proteomic Analysis Characterization of the Specificity of a Naturally-Occurring Monoclonal Anti-Thymocyte Autoantibody Derived From an Unimmunized, Neonatal Balb/c Mouse Autoantibodies to the Nuclear Phosphoprotein Nucleophosmin in Breast Cancer Patients Two Major Autoantigen-Antibody Systems of the Mitotic Spindle Apparatus cDNA Cloning and Characterization of a Novel Nucleolar Protein Occurrence of Autoantibody to Protein Disulfide Isomerase in Patients With Hepatic Disorder Potential Human Autoantigens by Protein Macroarrays Identification and Structure of Activated-Platelet Protein-1, a Protein With RNA-Binding Domain Motifs That Is Expressed by Activated Platelets Autoimmune Response to Proteins of Proliferating Cell Nuclear Antigen Multiprotein Complexes in Patients With Connective Tissue Diseases Protein Disulfide Isomerase A3-SpecificTh1EffectorCellsInfiltrate Colon Cancer Tissue of Patients With Circulating Anti-Protein Disulfide Isomerase A3 Autoantibodies Autoantibodies Against PFDN2 are Associated With an Increased Risk of Type 2 Diabetes: A Case-Control Study Cerebral Adrenoleukodystrophy is Associated With Loss of Tolerance to Profilin Identification of Candidate Endothelial Cell Autoantigens in Systemic Lupus Erythematosus Using a Molecular Cloning Strategy: A Role for Ribosomal P Protein P0 as an Endothelial Cell Autoantigen Paraneoplastic Pemphigus: A Short Review Autoantibodies Against Cyclophilin in Systemic Lupus Erythematosus and Lyme Disease Serum Proteomic-Based Analysis Identifying Autoantibodies Against PRDX2 and PRDX3 as Potential Diagnostic Biomarkers in Nasopharyngeal Carcinoma Identification of Specific and Common Diagnostic Antibody Markers for Gastrointestinal Cancers by SEREX Screening Using Testis cDNA Phage Library Autoantibodies in Primary Sjögren's Syndrome are Directed Against Proteasomal Subunits of the Alpha and Beta Type Proteasome Alpha-Type Subunit C9 is a Primary Target of Autoantibodies in Sera of Patients With Myositis and Systemic Lupus Erythematosus Characterization of Spermatozoa Surface Antigens by Antisperm Antibodies and its Influence on Acrosomal Exocytosis Novel Autoantibodies Against the Proteasome Subunit PSMA7 in Amyotrophic Lateral Sclerosis Autoimmune Reactivity Against the 20S-Proteasome Includes Immunosubunits LMP2 (Beta1i), MECL1 (Beta2i) and LMP7 (Beta5i) Immunoproteomics of HER2-Positive and HER2-Negative Breast Cancer Patients With Positive Lymph Nodes Identification of Autoantibodies to the I Protein of the Heterogeneous Nuclear Ribonucleoprotein Complex in Patients With Systemic Sclerosis PUF60: A Prominent New Target of the Autoimmune Response in Dermatomyositis and Sjögren's Syndrome The Protease Inhibitor Alpha-2-Macroglobulin-Like-1 is the P170 Antigen Recognized by Paraneoplastic Pemphigus Autoantibodies in Human Orderly Pattern of Development of the Autoantibody Response in (New Zealand White X BXSB)F1 Lupus Mice: Characterization of Target Antigens and Antigen Spreading by Two-Dimensional Gel Electrophoresis and Mass Spectrometry Epstein-Barr Virus-Induced Autoimmune Responses. I. Immunoglobulin M Autoantibodies to Proteins Mimicking and Not Mimicking Epstein-Barr Virus Nuclear Antigen-1 Antibody Against Chromatin Assembly Factor-1 Is a Novel Autoantibody Specifically Recognized in Systemic Lupus Erythematosus Radixin and Moesin Are Possible Auto-Immune Antigens in Rheumatoid Arthritis Autoantibodies Specific for the 20-KDal Ribosomal Large Subunit Protein L12 Anti-5s RNA/protein (RNP) Antibody Levels Correlate With Disease Activity in a Patient With Systemic Lupus Erythematosus (SLE) Nephritis Autoantibodies Against Eukaryotic Protein L7 in Patients Suffering From Systemic Lupus Erythematosus and Progressive Systemic Sclerosis: Frequency and Correlation With Clinical, Serological and Genetic Parameters. The SLE Study Group Properties of the Ribosomal P2 Protein Autoantigen Are Similar to Those of Foreign Protein Antigens Identification of Heat Shock Protein 90 and Other Proteins as Tumour Antigens by Serological Screening of an Ovarian Carcinoma Expression Library Heterogeneity of Ribosomal Autoantibodies From Human, Murine and Canine Connective Tissue Diseases A Small Nucleolar RNA is Processed From an Intron of the Human Gene Encoding Ribosomal Protein S3 Identification of a Novel Autoantibody Directed Against Small Ubiquitin-Like Modifier Activating Enzyme in Dermatomyositis Autoantibodies to Sweat Glands Detected by Different Methods in Serum and in Tissue From Patients Affected by a New Variant of Endemic Pemphigus Foliaceus Screening of an Endothelial cDNA Library Identifies the C-Terminal Region of Nedd5 as a Novel Autoantigen in Systemic Lupus Erythematosus With Psychiatric Manifestations The Prevalence and Clinical Significance of Autoantibodies to Plasminogen Activator Inhibitor 1 in Systemic Lupus Erythematosus Prevalence of HSP47 Antigen and Autoantibodies to HSP47 in the Sera of Patients With Mixed Connective Tissue Disease Identification of Anti-SF3B1 Autoantibody as a Diagnostic Marker in Patients With Hepatocellular Carcinoma Splicing Factor Proline/Glutamine-Rich Is a Novel Autoantigen of Dermatomyositis and Associated With Anti-Melanoma Differentiation-Associated Gene 5 Antibody Small Nucleolar RNP Scleroderma Autoantigens Associate With Phosphorylated Serine/Arginine Splicing Factors During Apoptosis Quantitative Radioligand Assays Using De Novo-Synthesized Recombinant Autoantigens in Connective Tissue Diseases: New Tools to Approach the Pathogenic Significance of Anti-RNP Antibodies in Rheumatic Diseases Lupus Autoantibodies Discriminate Between the Highly Homologous Sm Polypeptides B/B' and SmN by Binding an Epitope Restricted to B/B' The C-Terminal RG Dipeptide Repeats of the Spliceosomal Sm Proteins D1 and D3 Contain Symmetrical Dimethylarginines, Which Form a Major B-Cell Epitope for Anti-Sm Autoantibodies Anti-Sm Autoantibodies in Systemic Lupus Target Highly Basic Surface Structures of Complexed Spliceosomal Autoantigens Autoantibodies to Survival of Motor Neuron Complex in Patients With Polymyositis: Immunoprecipitation of D, E, F, and G Proteins Without Other Components of Small Nuclear Ribonucleoproteins Anti-Spectrin in Sera Containing Smooth Muscle Autoantibodies From Patients With Chronic Active Hepatitis Detection of Red Blood Cell Antibodies in Mitogen-Stimulated Cultures From Patients With Hereditary Spherocytosis High Prevalence of Autoantibodies Against the Nuclear High Mobility Group (HMG) Protein SSRP1 in Sera From Patients With Systemic Lupus Erythematosus, But Not Other Rheumatic Diseases Identification of Novel non-Myelin Biomarkers in Multiple Sclerosis Using an Improved Phage-Display Approach Decreased Serum Thrombospondin-1 and Elevation of Its Autoantibody Are Associated With Multiple Exacerbated Clinical Manifestations in Systemic Lupus Erythematosus Novel Serum Autoantibodies Against Talin1 in Multiple Sclerosis: Possible Pathogenetic Roles of the Antibodies Identification of an Immunodominant Peptide From Citrullinated Tenascin-C as a Major Target for Autoantibodies in Rheumatoid Arthritis Tropomyosin Isoforms in Intestinal Mucosa: Production of Autoantibodies to Tropomyosin Isoforms in Ulcerative Colitis Identification and Validation of Novel Serum Markers for Early Diagnosis of Endometriosis Anti-Endothelial Cell Antibodies in Patients With Cerebral Small Vessel Disease Autoantigens of the Nuclear Pore Complex Anti-Tubulin-Alpha-1C Autoantibody in Systemic Lupus Erythematosus: A Novel Indicator of Disease Activity and Vasculitis Manifestations Natural autoantibodies II. And Induced Antibodies Recognize Different Epitopes on the Tubulin Molecule Identification of Target Antigens of Naturally Occurring Autoantibodies in Cerebrospinal Fluid Identification of Beta-Tubulin Isoforms as Tumor Antigens in Neuroblastoma Autoantibody to Thioredoxin Reductase in an Ovarian Cancer Patient Clinical and Human Leucocyte Antigen Class II Haplotype Associations of Autoantibodies to Small Ubiquitin-Like Modifier Enzyme, a Dermatomyositis-Specific Autoantigen Target, in UK Caucasian Adult-Onset Myositis The Clinical Significance of Ubiquitin Carboxyl Hydrolase L1 and its Autoantibody in Neuropsychiatric Systemic Lupus Erythematosus Autoantibody-Targeted TAAs in Pancreatic Cancer: A Comprehensive Analysis Anti-P97/VCP Antibodies: An Autoantibody Marker for a Subset of Primary Biliary Cirrhosis Patients With Milder Disease? Autoimmunity to Vimentin Is Associated With Outcomes of Patients With Idiopathic Pulmonary Fibrosis Tryptophanyl-tRNA Synthetase as a Human Autoantigen Isolation and Characterization of cDNA Encoding the 80-kDa Subunit Protein of the Human Autoantigen Ku (P70/P80) Recognized by Autoantibodies From Patients With Scleroderma-Polymyositis Overlap Syndrome Single-Specificity Anti-Ku Antibodies in an International Cohort of 2140 Systemic Sclerosis Subjects: Clinical Associations. Med (Baltimore) Autism-Specific Maternal Autoantibodies Recognize Critical Proteins in Developing Brain cir Association With Clinical Features in Newly Diagnosed Giant Cell Arteritis Van Schaardenburg D. A Prospective Cohort Study of 14-3-3eta in ACPA and/ or RF-Positive Patients With Arthralgia Occurrence of Autoantibodies to Annexin I, 14-3-3 Theta and LAMR1 in Prediagnostic Lung Cancer Sera 14-3-3 in Thoracic Aortic Aneurysms: Identification of a Novel Autoantigen in Large Vessel Vasculitis Autoantibodies in Primary Sjogren's Syndrome are Directed Against Proteasomal Subunits of the Alpha and Beta Type Protein-Protein Association Networks With Increased Coverage, Supporting Functional Discovery in Genome-Wide Experimental Datasets Functional Complexity of the Axonal Growth Cone: A Proteomic Analysis The Proteome Profiles of the Olfactory Bulb of Juvenile, Adult and Aged Rats -an Ontogenetic Study Modulation of Neuronal Proteome Profile in Response to Japanese Encephalitis Virus Infection Mass Spectrometry Identification of Granins and Other Proteins Secreted by Neuroblastoma Cells Comprehensive Proteome Profiling of Glioblastoma-Derived Extracellular Vesicles Identifies Markers for More Aggressive Disease Unraveling the Complexity of Neurodegeneration in Brains of Subjects With Down Syndrome: Insights From Proteomics Proteins That Mediate Protein Aggregation and Cytotoxicity Distinguish Alzheimer's Hippocampus From Normal Controls Cerebral Ischemia Induces the Aggregation of Proteins Linked to Neurodegenerative Diseases The Parkinson's Disease-Linked Protein DJ-1 Associates With Cytoplasmic mRNP Granules During Stress and Neurodegeneration Coc Bladder Overactivity in a Mouse Model of Multiple Sclerosis Roles of Chondroitin Sulfate and Dermatan Sulfate in the Formation of a Lesion Scar and Axonal Regeneration After Traumatic Injury of the Mouse Brain White Matter Extracellular Matrix Chondroitin Sulfate/Dermatan Sulfate Proteoglycans in Multiple Sclerosis Dermatan Sulfate Promotes Neuronal Differentiation in Mouse and Human Stem Cells Glycosaminoglycan Neutralization in Coagulation Control Progression to Fibrosing Diffuse Alveolar Damage in a Series of 30 Minimally Invasive Autopsies With COVID-19 Pneumonia in Wuhan Converging Pathways in Pulmonary Fibrosis and Covid-19 -The Fibrotic Link to Disease Severity Melanocytic Activation in HIV-1 Disease: HMB-45 Staining in Common Acquired Nevi. Military Medical Consortium for the Advancement of Retroviral Research COVID-19 Associated With Sensorimotor Polyradiculoneuropathy and Skin Lesions: A Case Report Retina and Retinal Pigment Epithelial Cell Autoantibodies Are Produced During Murine Coronavirus Retinopathy Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies Topographic Changes in SARS Coronavirus-Infected Cells at Late Stages of Infection Nuclear Proteins Hijacked by Mammalian Cytoplasmic Plus Strand RNA Viruses Porcine Reproductive and Respiratory Syndrome Virus Strains With Higher Virulence Cause Marked Protein Profile Changes in MARC-145 Cells Proteome Response of Chicken Embryo Fibroblast Cells to Recombinant H5N1 Avian Influenza Viruses With Different Neuraminidase Stalk Lengths Host-and Strain-Specific Regulation of Influenza Virus Polymerase Activity by Interacting Cellular Proteins Multi-Faceted Proteomic Characterization of Host Protein Complement of Rift Valley Fever Virus Virions and Identification of Specific Heat Shock Proteins, Including HSP90, as Important Viral Host Factors iTRAQ-Based Proteomics Identification of Serum Biomarkers of Two Chronic Hepatitis B Subtypes Diagnosed by Traditional Chinese Medicine Analysis of Networks of Host Proteins in the Early Time Points Following HIV Transduction HIV-1 Remodels the Nuclear Pore Complex HIV-1 and Two Avian Retroviral 5' Untranslated Regions Bind Orthologous Human and Chicken RNA Binding Proteins Proteomic Analysis of Secretomes of Oncolytic Herpes Simplex Virus-Infected Squamous Cell Carcinoma Cells Do Viral Infections Protect From or Enhance Type 1 Diabetes and How can We Tell the Difference? Treatment of Antisynthetase-Associated Interstitial Lung Disease With Tacrolimus Glutamyl-Prolyl-tRNA Synthetase Regulates Proline-Rich Pro-Fibrotic Protein Synthesis During Cardiac Fibrosis A Recurrent WARS Mutation Is a Novel Cause of Autosomal Dominant Distal Hereditary Motor Neuropathy New-Onset IgG Autoantibodies in Hospitalized Patients With COVID-19 A Graphical Gene-Set Enrichment Tool for Animals and Plants We thank Jung-hyun Rho for technical assistance with experiments. We thank Ross Tomaino and the Taplin Biological Mass Spectrometry facility of Harvard Medical School for expert service with protein sequencing. The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2022. 831849/full#supplementary-material Conflict of Interest: JW is the founder and Chief Scientific Officer of Curandis. MWR and VR are volunteers of Curandis. MHR is a member of the Scientific Advisory Boards of Trans-Hit Bio (Azenta Life Sciences), Proscia, and Universal DX.The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Publisher's Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.Copyright © 2022 Wang, Zhang, Roehrl, Roehrl and Roehrl. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.